I have long held the belief that digital therapeutics will be prescribed alongside drugs to improve patient outcomes, leading ...

The University of Pittsburgh was awarded $8 million to continue researching a new therapy for Parkinson's patients.

Pharma Two B Ltd. ("Pharma Two B”), a late-clinical stage company that is developing P2B001, an innovative combination ...

IBN ? Annovis Bio, Inc. ("Annovis" or the "Company"), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, such as Alzheimer's disease (AD) and Parkinson's ...

An electronic nose created by scientists in Tartu may be able to diagnose serious neurological diseases such as Parkinson's ...

For decades, the medical world has avidly searched for groundbreaking treatments against one of humanity’s most resilient ...

AlzeCure Pharma AB (publ) (FN STO:ALZCUR) today announced that its interim report for the period January - September 2024 is now available on the company's ...

STOCKHOLM, SE / ACCESSWIRE / November 11, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR) today announced that its interim report for the period January - Septem ...

Factors associated with ageing that can increase falls risk include loss of muscle strength and balance, orthostatic hypotension, and visual and functional impairments. Older people may also have ...

Unexplained weight loss is a noticeable drop in body weight when you are not even trying to lose any weight. And so, since you are not on a calorie-limited diet or have been doing physical exercises ...

Is there anything I can do to lower my risk of developing Parkinson’s disease ... developing Parkinson’s disease. However, taking steps to improve your gut’s lining — like minimizing nonsteroidal anti ...

The past four years have brought disappointment for the Huntington’s community, but optimism is growing as companies ...